Clinical Trials Logo
  1. Home
  2. Central Nervous System Tumors
  3. NCT01052363

OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas

Central Nervous System Tumors Clinical Trial

Official title:
OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas

Clinical Trial Summary

Pilot Trial of CA4P with Avastin in Recurrent Gliomas

Clinical Trial Description

The purpose of this study is to see if fosbretabulin, the drug being studied, combined with bevacizumab will help your brain cancer and if using these drugs together is safe. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01052363
Study type Interventional
Source West Virginia University
Contact
Status Withdrawn
Phase Phase 1
Start date January 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT00876993 - Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors Phase 1
Completed NCT00003935 - Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma Phase 1
Terminated NCT00107471 - Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma Phase 1/Phase 2
Completed NCT00003573 - Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma Phase 2
Recruiting NCT05235074 - OH2 Oncolytic Viral Therapy in Central Nervous System Tumors Phase 1/Phase 2
Suspended NCT05308407 - POWER UP: Participating Online While Exercising to Recover Using Play N/A
Terminated NCT00477503 - Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA Phase 1
Active, not recruiting NCT01985451 - Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL） Phase 2
Withdrawn NCT00109798 - Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma N/A
Completed NCT00003203 - Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors Phase 2
Completed NCT00003141 - Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors Phase 1
Completed NCT02462629 - Study of BLZ-100 in Pediatric Subjects With CNS Tumors Phase 1
Active, not recruiting NCT01735747 - Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma Phase 2
Recruiting NCT00607984 - Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors N/A
Completed NCT00899834 - DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma N/A
Completed NCT00066248 - Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment Phase 2
Completed NCT00187226 - A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects Phase 2
Completed NCT02793466 - Durvalumab in Pediatric and Adolescent Patients Phase 1
Completed NCT00047320 - Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors Phase 2
Completed NCT00945828 - Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors N/A